Practitioner Information

The Genostics testing service utilises the most advanced molecular medicine techniques to:

  • Provide a Circulating Tumour Cell (CTC) count to follow up and monitor the effectiveness of a person's treatment
  • Analyse the sensitivity or resistance of a person's CTCsto chemotherapeutic agents and selected botanicals. This is achieved via in-vitro chemosensitivity testing of CTCs.
  • Identify tumour biomarkers present on CTCs. Practitioners obtain valuable information about the genetics of an individual persons cancer, and targets for treatment that include population of the metastatic cells.

For information on test selection, practitioners may contact medical director Dr. Joachim Fluhrer via the Genostics office on +1300 282 482

Detection, identification and enumeration of CTCs ...CTC Count practitioner info


In vitro chemosensitivity testing of recommended treatments ... Chemosensitivity test practitioner info

Biomarker test for treatment targets and aggressive indicators ...Companion diagnostics practitioner info


CTCs capable of forming clusters are associated with increased metastatic risk ...Tumour sphere units practitioner info